FH535

CAS No. 108409-83-2

FH535( FH 535 | FH-535 )

Catalog No. M10331 CAS No. 108409-83-2

A dual PPARγ/δ antagonist that is able to inhibit GRIP1 and β-catenin recruitment.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 29 In Stock
10MG 47 In Stock
25MG 86 In Stock
50MG 150 In Stock
100MG 259 In Stock
200MG 383 In Stock
500MG 619 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    FH535
  • Note
    Research use only, not for human use.
  • Brief Description
    A dual PPARγ/δ antagonist that is able to inhibit GRIP1 and β-catenin recruitment.
  • Description
    A dual PPARγ/δ antagonist that is able to inhibit GRIP1 and β-catenin recruitment; antagonizes β-catenin/Tcf–mediated transcription and inhibits the Wnt/β-catenin pathway; shows antiproliferation effect on transformed colon lung and liver cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    FH 535 | FH-535
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Beta-catenin
  • Recptor
    PPARγ|PPARδ|Wnt/β-catenin
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    108409-83-2
  • Formula Weight
    361.2005
  • Molecular Formula
    C13H10Cl2N2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=S(C1=CC(Cl)=CC=C1Cl)(NC2=CC=C([N+]([O-])=O)C=C2C)=O
  • Chemical Name
    Benzenesulfonamide, 2,5-dichloro-N-(2-methyl-4-nitrophenyl)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Handeli S, et al. Mol Cancer Ther. 2008 Mar;7(3):521-9. 2. Gedaly R, et al. PLoS One. 2014 Jun 18;9(6):e99272. 3. Su H, et al. J Transl Med. 2015 Mar 31;13:104.
molnova catalog
related products
  • iCRT-3

    iCRT-3 is a selective, cell-permeable β-catenin responsive transcription (CRT) inhibitor with IC50 of 8.2 nM.

  • CCT-031374 hydrobrom...

    A novel small-molecule Wnt signaling inhibitor that inhibits TCF-dependent transcription with IC50 of 6.1 uM in 7dF3 reporter assay.

  • β-catenin-IN-11a

    β-catenin-IN-11a is a β-catenin/CD44/Nanog axis inhibitor, docks into the β-catenin allosteric site and interferes β-catenin/TCF-4 complex.